Analysed MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) News Sources
How Investors Are Reacting To MoonLake Immunotherapeutics (MLTX) Long-Term Sonelokimab Data In Hidradenitis Suppurativa
05-04-2026
yahoo.com
MoonLake Trial Data Continue to Support Efficacy of Sonelokimab to Treat Hidradenitis Suppurativa, Wedbush Says
30-03-2026
yahoo.com
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
28-03-2026
yahoo.com
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
16-03-2026
fool.com
Goldman Questions MoonLake Immunotherapeutics’ (MLTX) Sonelokimab Approval Odds Despite Pipeline Update
02-03-2026
yahoo.com
Assessing MoonLake Immunotherapeutics (MLTX) Valuation After Mixed Share Price Performance And Premium P/B Ratio
01-03-2026
yahoo.com
What is the current price of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The current price of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is $17.96.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) since the previous trading day is $-1.45.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) since the previous trading day is -7.4704%.
What is the most recent average sentiment score for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The most recent average sentiment score for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is 47 out of 100.
What is the most recent average sentiment for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The most recent sentiment for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is .
SEC-8K** Filing Available For MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.